Terminal Differentiation, Advanced Organotypic Maturation, and Modeling of Hypertrophic Growth in Engineered Heart Tissue

Rationale: Cardiac tissue engineering should provide “realistic” in vitro heart muscle models and surrogate tissue for myocardial repair. For either application, engineered myocardium should display features of native myocardium, including terminal differentiation, organotypic maturation, and hypertrophic growth. Objective: To test the hypothesis that 3D-engineered heart tissue (EHT) culture supports (1) terminal differentiation as well as (2) organotypic assembly and maturation of immature cardiomyocytes, and (3) constitutes a methodological platform to investigate mechanisms underlying hypertrophic growth. Methods and Results: We generated EHTs from neonatal rat cardiomyocytes and compared morphological and molecular properties of EHT and native myocardium from fetal, neonatal, and adult rats. We made the following key observations: cardiomyocytes in EHT (1) gained a high level of binucleation in the absence of notable cytokinesis, (2) regained a rod-shape and anisotropic sarcomere organization, (3) demonstrated a fetal-to-adult gene expression pattern, and (4) responded to distinct hypertrophic stimuli with concentric or eccentric hypertrophy and reexpression of fetal genes. The process of terminal differentiation and maturation (culture days 7–12) was preceded by a tissue consolidation phase (culture days 0–7) with substantial cardiomyocyte apoptosis and dynamic extracellular matrix restructuring. Conclusions: This study documents the propensity of immature cardiomyocytes to terminally differentiate and mature in EHT in a remarkably organotypic manner. It moreover provides the rationale for the utility of the EHT technology as a methodological bridge between 2D cell culture and animal models.

[1]  L. Carrier,et al.  Cardiac Myosin-Binding Protein C Is Required for Complete Relaxation in Intact Myocytes , 2007, Circulation research.

[2]  Whalen Wj.  Intracellular PO2 in heart and skeletal muscle. , 1971 .

[3]  Thomas Eschenhagen,et al.  Engineering Myocardial Tissue , 2005, Circulation research.

[4]  A. Gerdes,et al.  Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. , 1996, Journal of molecular and cellular cardiology.

[5]  W. Zimmermann,et al.  Tissue Engineering of a Differentiated Cardiac Muscle Construct , 2002, Circulation research.

[6]  F J Schoen,et al.  Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. , 1999, Biotechnology and bioengineering.

[7]  S. Rosenkranz,et al.  PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue. , 2010, Journal of molecular and cellular cardiology.

[8]  Yihua Loo,et al.  Novel anisotropic engineered cardiac tissues: studies of electrical propagation. , 2007, Biochemical and biophysical research communications.

[9]  H. Eppenberger,et al.  Reexpression of α-smooth muscle actin isoform in cultured adult rat cardiomyocytes , 1990 .

[10]  H. Eppenberger,et al.  Reexpression of alpha-smooth muscle actin isoform in cultured adult rat cardiomyocytes. , 1990, Developmental biology.

[11]  R. Harris,et al.  The predominance of binucleation in isolated rat heart myocytes. , 1977, The American journal of anatomy.

[12]  P. Anversa,et al.  Morphometric Study of Early Postnatal Development in the Left and Right Ventricular Myocardium of the Rat: I. Hypertrophy, Hyperplasia, and Binucleation of Myocytes , 1980, Circulation research.

[13]  Thomas Eschenhagen,et al.  Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Milica Radisic,et al.  Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Maulik,et al.  Cardiac genomic response following preconditioning stimulus. , 2006, Cardiovascular research.

[16]  W. Zimmermann,et al.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. , 2000, Biotechnology and bioengineering.

[17]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[18]  Wolfram-Hubertus Zimmermann,et al.  Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle , 2006, Circulation.

[19]  Mitsuo Umezu,et al.  Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces , 2002, Circulation research.

[20]  C. Chassagne,et al.  Regulation of myosin heavy chain and actin isogenes expression during cardiac growth , 1991, Molecular and Cellular Biochemistry.

[21]  G. Breier,et al.  Cardiomyocyte-specific Prolyl-4-hydroxylase Domain 2 Knock Out Protects from Acute Myocardial Ischemic Injury* , 2011, The Journal of Biological Chemistry.

[22]  W. Whalen.  Intracellular PO2 in heart and skeletal muscle. , 1971, The Physiologist.

[23]  Todd C McDevitt,et al.  Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. , 2003, Journal of biomedical materials research. Part A.

[24]  M. Franklin,et al.  Cardiomyocyte DNA synthesis and binucleation during murine development. , 1996, The American journal of physiology.

[25]  H. Eppenberger,et al.  Cellular engineering of ventricular adult rat cardiomyocytes. , 2003, Cardiovascular research.

[26]  Andreas Hess,et al.  Cardiac Grafting of Engineered Heart Tissue in Syngenic Rats , 2002, Circulation.

[27]  R. Gerrity,et al.  Age‐Related Changes in Ploidy Levels and Biochemical Parameters in Cardiac Myocytes Isolated from Spontaneously Hypertensive Rats , 1986, Circulation research.

[28]  S. Meloche,et al.  Extracellular Signal-Regulated Kinases 1 and 2 Regulate the Balance Between Eccentric and Concentric Cardiac Growth , 2011, Circulation research.

[29]  Andreas Hess,et al.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts , 2006, Nature Medicine.

[30]  P. D. de Tombe,et al.  Functional consequences of caspase activation in cardiac myocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Whitesides,et al.  Muscular Thin Films for Building Actuators and Powering Devices , 2007, Science.

[32]  J. Griepentrog,et al.  Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction. , 2006, Cardiovascular research.

[33]  Milica Radisic,et al.  Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue , 2006, Biotechnology and bioengineering.

[34]  B. Nadal-Ginard,et al.  Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. , 1984, The Journal of biological chemistry.

[35]  R. Weisel,et al.  Survival and function of bioengineered cardiac grafts. , 1999, Circulation.

[36]  Lisa E. Freed,et al.  Accordion-Like Honeycombs for Tissue Engineering of Cardiac Anisotropy , 2008, Nature materials.

[37]  G Olivetti,et al.  Morphometric Study of Early Postnatal Development in the Left and Right Ventricular Myocardium of the Rat: II. Tissue Composition, Capillary Growth, and Sarcoplasmic Alterations , 1980, Circulation research.

[38]  J. Leor,et al.  Bioengineered Cardiac Grafts: A New Approach to Repair the Infarcted Myocardium? , 2000, Circulation.